Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer
Authors:
- 24 November 2023
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 51 (1-2) , 36-44
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian CancerNew England Journal of Medicine, 2012
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Synthetic lethality of PARP inhibition in cancers lackingBRCA1andBRCA2mutationsCell Cycle, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum ResistanceCancer Research, 2008
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancersNature, 2008
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004